Shoshana Shendelman - 30 Nov 2023 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Shoshana Shendelman
Issuer symbol
APLT
Transactions as of
30 Nov 2023
Net transactions value
-$7,817
Form type
4
Filing time
01 Dec 2023, 19:42:56 UTC
Previous filing
29 Sep 2023
Next filing
22 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Sale $7,817 -3,968 -0.15% $1.97 2,596,387 30 Nov 2023 Direct F1
holding APLT Common Stock 1,750,000 30 Nov 2023 See footnote F2
holding APLT Common Stock 1,492,094 30 Nov 2023 See footnote F3
holding APLT Common Stock 709,720 30 Nov 2023 See footnote F4
holding APLT Common Stock 290,280 30 Nov 2023 See footnote F5
holding APLT Common Stock 88,397 30 Nov 2023 See footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
F2 Through a grantor retained annuity trust.
F3 Through a family trust controlled by the reporting person's spouse.
F4 Through the reporting person's spouse.
F5 Through a family trust controlled by the reporting person.
F6 Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.